ALL KEYWORDSSecondary Progressive Multiple Sclerosis (SPMS)Related SpecialistsShowing 3 of 24Erin LongbrakeMD, PhDDavid A. HaflerMD, MScSrinath KadimiMDMore Related SpecialistsRelated Clinical TrialsIdentifying and Characterizing Preclinical MSBrain, Spinal Cord & Nervous SystemGender:All GendersAge:13 years and olderEfficacy and safety study of frexalimab (SAR441344) in adults with nonrelapsing secondary progressive Multiple SclerosisGender:All GendersAge:18 years - 60 yearsRelated NewsResearch & InnovationDoctors & AdviceResearch & InnovationRelated DepartmentsShowing 3 of 11NeurologyOrthopaedics & RehabilitationMultiple Sclerosis & Other Inflammatory Brain DiseaseMore Related Departments
